SYNTHROID DONG STUDY "LESSONS LEARNED": SPONSOR VETO POWER SHOULD NOT BE ACCEPTED -- JAMA EDITOR; FORMER HHS SECRETARY SULLIVAN NEGOTIATES PUBLICATION
Executive Summary
The dispute regarding the Dong et al. study of Knoll's Synthroid demonstrates that researchers should not sign contracts allowing sponsors to veto publishing decisions, a Journal of the American Medical Association editorial states.
You may also be interested in...
ClinicalTrials.Gov Registry Needs Legislative Boost, JAMA Editorial Says
Congress needs to add funding and enforcement tools to the legislation creating the ClinicalTrials.gov clinical trials registry, a "special communication" in the July 23/30 issue of the Journal of the American Medical Association says
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011